Elena Brevnova has an extensive background in molecular biology, with experience in leading and managing teams in various companies such as Conagen, Ginkgo Bioworks, Evelo Therapeutics, TOTAL New Energies, Mascoma Corp., and Merck. Elena has a Ph.D. in Molecular Biology from GosNIIgenetika and a B.S./M.S. in Radiation Biophysics and Ecology from National Research Nuclear University MEPhI. Elena has expertise in metabolic engineering, organism engineering, strain development, and molecular biology research.
August, 2022 - present